SIBTime Phase II: Web Application for Typically Developing Siblings
Launched by OREGON RESEARCH BEHAVIORAL INTERVENTION STRATEGIES, INC. · Oct 19, 2023
Trial Information
Current as of July 05, 2025
Recruiting
Keywords
ClinConnect Summary
The SIBTime Phase II trial is studying a new web application designed to help typically developing siblings (ages 3-6) of children with disabilities. This app aims to provide parents and kids with helpful information and tools to support the social and emotional well-being of these siblings. The goal is to create engaging family routines that nurture their development, particularly focusing on families from ethnic minority backgrounds and those living in rural areas, who often lack adequate resources.
To participate in the trial, you must be a parent of a child who has a disability and also have a typically developing child aged between 3 to 6 years. You’ll need access to a smartphone or tablet and should be able to speak either English or Spanish. There are no specific exclusions for this trial, making it accessible for many families. If you join, you can expect to use the SIBTime app, which will help you and your child learn and grow together in a supportive environment.
Gender
ALL
Eligibility criteria
- Criteria:
- Inclusion criteria:
- • 1. Parent of a child with a disability and a typically developing child aged 3-6
- • 2. Has a smartphone or tablet
- • 3. Speaks English or Spanish
- Exclusion criteria:
- • 1. None
About Oregon Research Behavioral Intervention Strategies, Inc.
Oregon Research Behavioral Intervention Strategies, Inc. is a dedicated clinical trial sponsor focused on advancing innovative behavioral health solutions. With a commitment to improving patient outcomes, the organization specializes in designing, implementing, and evaluating evidence-based interventions that address a range of psychological and behavioral health challenges. Leveraging a multidisciplinary approach, Oregon Research aims to foster collaboration among researchers, healthcare providers, and community stakeholders, ensuring that their studies not only meet rigorous scientific standards but also translate effectively into real-world applications. Through its comprehensive research initiatives, the organization strives to contribute to the enhancement of mental health care and the overall well-being of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Springfield, Oregon, United States
Patients applied
Trial Officials
Jessie Marquez, BA
Principal Investigator
Oregon Research Behavioral Intervention Strategies, Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported